---  
layout: startup_page  
title: "Evommune"  
id: "evommune.com"  
permalink: "/evommuneevommune.com10312024/"  
website: "https://www.evommune.com/"  
funding_round: "Series C"  
funding_amount: "$115M"  
investors: "RA Capital Management, Sectoral Asset Management, B Capital, Marshall Wace, Avego Bioscience Capital, Longwood Fund, RTW Investments, ADAR1 Capital Management, NEXTBio Capital, Beiersdorf Venture Capital, FemHealth Ventures, Allostery Investments LP, Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners, Amplitude Ventures, SymBiosis, Verition Fund Management"  
about: "Evommune, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel treatments for immune-mediated inflammatory diseases. The company is advancing innovative therapies, such as EVO756 and EVO301, aimed at addressing symptoms and halting disease progression. Their goal is to provide new treatment options for patients suffering from chronic inflammatory conditions."  
markets: "Biotechnology, Immunology, Pharmaceuticals, Health Care, Life Science, Drug Discovery"  
hq: "Palo Alto, California, United States"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/evommune"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/evommune"  
pitchbook: "https://pitchbook.com/profiles/company/453499-48"  

date_display: "31-Oct-2024"  
date: "2024-10-31"

# SEO Optimization  
meta_title: "Evommune - Series C Funding ($115M)"  
meta_description: "Evommune, Evommune, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel treatments for immune-mediated inflammatory disea..."  
meta_keywords: "Evommune, Biotechnology, Immunology, Pharmaceuticals, Health Care, Life Science, Drug Discovery, Series C funding"  
canonical_url: "https://startup.projectstartups.com/evommuneevommune.com10312024/"  
---